Medicine and Dentistry
Bladder Cancer
100%
Cisplatin
100%
Cyclophosphamide
100%
Doxorubicin
100%
Disease Free Survival
100%
Adjuvant Chemotherapy
100%
Neoplasm
66%
Primary Tumor
66%
Nodal Metastasis
66%
Cystectomy
66%
Lymph Duct
66%
Pelvis
33%
Recurrent Disease
33%
Contraindication
33%
Aminophylline
33%
Pelvic Viscera
33%
Diseases
33%
Keyphrases
Chemotherapy
100%
Cyclophosphamide
100%
Bladder Cancer
100%
Doxorubicin Treatments
100%
Cisplatin-based Chemotherapy
100%
High Risk
42%
Pathological Findings
42%
Adjuvant Chemotherapy
42%
Primary Tumor
28%
Risk for Relapse
28%
Nodal Metastasis
28%
Cystectomy
28%
Long-term Disease-free Survival
28%
Cisplatin
14%
Doxorubicin
14%
Disease-free Survival
14%
Columbus
14%
Survival Benefit
14%
Tumor Invasion
14%
Lymphovascular Invasion
14%
Adriamycin
14%
Disease-free
14%
Bristol
14%
Pelvic Peritoneum
14%
Poor Prognostic
14%
Direct Invasion
14%
Prognostic Features
14%
Medical Contraindications
14%
Adria
14%
Tumor Lymphatics
14%
Cytoxan
14%
Nursing and Health Professions
Bladder Cancer
100%
Doxil
100%
Cyclophosphamide
100%
Cisplatin
100%
Adjuvant Chemotherapy
100%
Disease Free Survival
100%
Neoplasm
66%
Primary Tumor
66%
Cystectomy
66%
Recurrent Disease
33%
Contraindication
33%
Aminophylline
33%
Diseases
33%